Repros Therapeutics Inc (NASDAQ:RPRX)

8.57
Delayed Data
As of Mar 27
 +0.01 / +0.12%
Today’s Change
5.92
Today|||52-Week Range
22.55
-14.04%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Repros Therapeutics Inc have a median target of 31.50, with a high estimate of 41.00 and a low estimate of 13.00. The median estimate represents a +267.56% increase from the last price of 8.57.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Repros Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.31
Sales
$0.00
Reporting Date
May 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.81%
 
 
 
 
 
 
Growthannually 13.19%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account